{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:30:49Z","timestamp":1721003449654},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,14]]},"DOI":"10.7759\/cureus.64519","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:54:13Z","timestamp":1720965253000},"source":"Crossref","is-referenced-by-count":0,"title":["Unplanned 30-Day Readmissions After Hospitalization for Irritable Bowel Syndrome"],"prefix":"10.7759","author":[{"given":"Joshua O","family":"Ugboke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidelis","family":"Uwumiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efeturi M","family":"Okorigba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridwan A","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victory","family":"Okpujie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwunonso","family":"Ndulue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Love  O","family":"Temple-Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel I","family":"Bassey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulraheem E","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ozumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford AC","year":"2020","unstructured":"Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020, 396:1675-88. 10.1016\/S0140-6736(20)31548-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6110099","article-title":"Rome criteria and a diagnostic approach to irritable bowel syndrome","volume":"6","author":"Lacy BE","year":"2017","unstructured":"Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017, 6:99. 10.3390\/jcm6110099","journal-title":"J Clin Med"},{"key":"ref3","unstructured":"American college of Gastroenterology (ACG 2023). Irritable Bowel Syndrome. (2023). Accessed: August 23, 2023: https:\/\/gi.org\/topics\/irritable-bowel-syndrome\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12938","article-title":"Review article: the economic impact of the irritable bowel syndrome","volume":"40","author":"Canavan C","year":"2014","unstructured":"Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014, 40:1023-34. 10.1111\/apt.12938","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1031-z","article-title":"Healthcare use by 30,000 patients with irritable bowel syndrome (IBS) in France: a 5-year retrospective and one-year prospective national observational study","volume":"19","author":"Sabat\u00e9 JM","year":"2019","unstructured":"Sabat\u00e9 JM, Rivi\u00e8re S, Jouet P, Gastaldi-Menager C, Fagot-Campagna A, Tuppin P. Healthcare use by 30,000 patients with irritable bowel syndrome (IBS) in France: a 5-year retrospective and one-year prospective national observational study. BMC Gastroenterol. 2019, 19:111. 10.1186\/s12876-019-1031-z","journal-title":"BMC Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2022.0754","article-title":"Epidemiology of irritable bowel syndrome in hospitalized patients with inflammatory bowel disease: Nationwide Inpatient Sample analysis from 2007-2016","volume":"35","author":"Shin C","year":"2022","unstructured":"Shin C, Ali S, Hussain S, Trivedi I, Gao Y, Shuja A. Epidemiology of irritable bowel syndrome in hospitalized patients with inflammatory bowel disease: Nationwide Inpatient Sample analysis from 2007-2016. Ann Gastroenterol. 2022, 35:603-8. 10.20524\/aog.2022.0754","journal-title":"Ann Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-0985-1","article-title":"Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries","volume":"19","author":"Tack J","year":"2019","unstructured":"Tack J, Stanghellini V, Mearin F, et al.. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol. 2019, 19:69. 10.1186\/s12876-019-0985-1","journal-title":"BMC Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2020.08.015","article-title":"National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: an analysis from the Nationwide Readmissions Database, 2012-2016","volume":"231","author":"Yerasi C","year":"2021","unstructured":"Yerasi C, Tripathi B, Wang Y, et al.. National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: an analysis from the Nationwide Readmissions Database, 2012-2016. Am Heart J. 2021, 231:25-31. 10.1016\/j.ahj.2020.08.015","journal-title":"Am Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15171\/mejdd.2019.130","article-title":"Post-infectious irritable bowel syndrome: a narrative review","volume":"11","author":"Sadeghi A","year":"2019","unstructured":"Sadeghi A, Biglari M, Nasseri Moghaddam S. Post-infectious irritable bowel syndrome: a narrative review. Middle East J Dig Dis. 2019, 11:69-75. 10.15171\/mejdd.2019.130","journal-title":"Middle East J Dig Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/262478","article-title":"Low risk of irritable bowel syndrome after Clostridium difficile infection","volume":"21","author":"Piche T","year":"2007","unstructured":"Piche T, Vanbiervliet G, Pipau FG, Dainese R, H\u00e9buterne X, Rampal P, Collins SM. Low risk of irritable bowel syndrome after Clostridium difficile infection. Can J Gastroenterol. 2007, 21:727-31. 10.1155\/2007\/262478","journal-title":"Can J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2736-1","article-title":"Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and\/or the solution of a conundrum?","volume":"75","author":"Bassotti G","year":"2018","unstructured":"Bassotti G, Macchioni L, Corazzi L, Marconi P, Fettucciari K. Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and\/or the solution of a conundrum?. Cell Mol Life Sci. 2018, 75:1145-9. 10.1007\/s00018-017-2736-1","journal-title":"Cell Mol Life Sci"},{"key":"ref12","article-title":"Inflammatory bowel disease readmissions are associated with utilization and comorbidity","volume":"25","author":"Cohen-Mekelburg S","year":"2019","unstructured":"Cohen-Mekelburg S, Rosenblatt R, Wallace B. Inflammatory bowel disease readmissions are associated with utilization and comorbidity. Am J Manag Care. 2019, 25:474-81.","journal-title":"Am J Manag Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00794-z","article-title":"Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management","volume":"20","author":"Staudacher HM","year":"2023","unstructured":"Staudacher HM, Black CJ, Teasdale SB, Mikocka-Walus A, Keefer L. Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol. 2023, 20:582-96. 10.1038\/s41575-023-00794-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.015","article-title":"Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization","volume":"10","author":"Ladabaum U","year":"2012","unstructured":"Ladabaum U, Boyd E, Zhao WK, et al.. Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol. 2012, 10:37-45. 10.1016\/j.cgh.2011.08.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-832","article-title":"Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care","volume":"13","author":"Faresj\u00f6 \u00c5","year":"2013","unstructured":"Faresj\u00f6 \u00c5, Grodzinsky E, Hallert C, Timpka T. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care. BMC Public Health. 2013, 13:832. 10.1186\/1471-2458-13-832","journal-title":"BMC Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001498","article-title":"Cannabis use is associated with reduced 30-day all-cause readmission among hospitalized patients with irritable bowel syndrome: a nationwide analysis","volume":"56","author":"Choi C","year":"2022","unstructured":"Choi C, Abougergi M, Peluso H, Weiss SH, Nasir U, Pyrsopoulos N. Cannabis use is associated with reduced 30-day all-cause readmission among hospitalized patients with irritable bowel syndrome: a nationwide analysis. J Clin Gastroenterol. 2022, 56:257-65. 10.1097\/MCG.0000000000001498","journal-title":"J Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8008","article-title":"Association Between Cannabis Use and Healthcare Utilization in Patients With Irritable Bowel Syndrome: A Retrospective Cohort Study","volume":"12","author":"Desai P","year":"2020","unstructured":"Desai P, Mbachi C, Vohra I, et al.. Association Between Cannabis Use and Healthcare Utilization in Patients With Irritable Bowel Syndrome: A Retrospective Cohort Study. Cureus. 2020, 12:e8008. 10.7759\/cureus.8008","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.01.017","article-title":"The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect health care costs","volume":"21","author":"Bosman MH","year":"2023","unstructured":"Bosman MH, Weerts ZZ, Snijkers JT, et al.. The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect health care costs. Clin Gastroenterol Hepatol. 2023, 21:2660-9. 10.1016\/j.cgh.2023.01.017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.16138","article-title":"Economic burden of irritable bowel syndrome with diarrhea: retrospective analysis of a U.S. commercially insured population","volume":"23","author":"Buono JL","year":"2017","unstructured":"Buono JL, Mathur K, Averitt AJ, Andrae DA. Economic burden of irritable bowel syndrome with diarrhea: retrospective analysis of a U.S. commercially insured population. J Manag Care Spec Pharm. 2017, 23:453-60. 10.18553\/jmcp.2016.16138","journal-title":"J Manag Care Spec Pharm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05933-1","article-title":"A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome","volume":"12","author":"Poon D","year":"2022","unstructured":"Poon D, Law GR, Major G, Andreyev HJ. A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome. Sci Rep. 2022, 12:1949. 10.1038\/s41598-022-05933-1","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2020.04.190328","article-title":"Misdiagnosis of diverticulitis after a prior diagnosis of irritable bowel syndrome (IBS)","volume":"33","author":"Longstreth GF","year":"2020","unstructured":"Longstreth GF, Wong C, Chen Q. Misdiagnosis of diverticulitis after a prior diagnosis of irritable bowel syndrome (IBS). J Am Board Fam Med. 2020, 33:549-60. 10.3122\/jabfm.2020.04.190328","journal-title":"J Am Board Fam Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2223975","article-title":"Irritable bowel syndrome - controversies in diagnosis and management","volume":"17","author":"Duncanson K","year":"2023","unstructured":"Duncanson K, Tikhe D, Williams GM, Talley NJ. Irritable bowel syndrome - controversies in diagnosis and management. Expert Rev Gastroenterol Hepatol. 2023, 17:649-63. 10.1080\/17474124.2023.2223975","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185802-unplanned-30-day-readmissions-after-hospitalization-for-irritable-bowel-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:54:18Z","timestamp":1720965258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185802-unplanned-30-day-readmissions-after-hospitalization-for-irritable-bowel-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,14]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.64519","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,14]]}}}